Skip to main content

Animations

MJFF Publications

2691 - 2700 of 6564 Results
Title
Year
  • Year
  • 2018
  • 2020
  • 2012
  • 2025
  • 2025
  • 2010
  • 2017
  • 2018
  • 2018
  • 2019
  • Summary Details
    OPEN
    Title: Interactome Screening Identifies the ER Luminal Chaperone Hsp47 as a Regulator of the Unfolded Protein Response Transducer IRE1α
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.molcel.2017.12.028
    Citation Count: 165
  • Summary Details
    OPEN
    Title: Association of MAPT subhaplotypes with clinical and demographic features in Parkinson’s disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/acn3.51139
    Citation Count: 11
  • Summary Details
    OPEN
    Title: GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.06.104
    Citation Count: 151
  • Summary Details
    OPEN
    Title: TBK1 Induces the Formation of Optineurin Filaments That Condensate with Polyubiquitin and LC3 for Cargo Sequestration
    Journal Name: Advanced Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/advs.202509927
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Sex differences in the diagnosis latency of Parkinson's disease in Latin America
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107344
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2010.05.001
    Citation Count: 151
  • Summary Details
    OPEN
    Title: BRAPH: A graph theory software for the analysis of brain connectivity
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0178798
    Citation Count: 260
  • Summary Details
    OPEN
    Title: Circular RNA expression and regulatory network prediction in posterior cingulate astrocytes in elderly subjects
    Journal Name: BMC Genomics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12864-018-4670-5
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Genetic variants associated with Alzheimer’s disease confer different cerebral cortex cell-type population structure
    Journal Name: Genome Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13073-018-0551-4
    Citation Count: 70
  • Summary Details
    OPEN
    Title: Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-019-0469-0
    Citation Count: 149
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.